Interferon therapy in myelofibrosis - a systematic review and meta-analysis

BACKGROUND: Myelofibrosis is a Philadelphia chromosome-negative myeloproliferative neoplasm characterized by progressive bone marrow failure, increased risk of progression to AML, and constitutional symptoms. For over three decades various formulations of interferon (IFN) have been used for the trea...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Lymphoma Myeloma Leuk
Main Authors: Bewersdorf, Jan Philipp, Giri, Smith, Wang, Rong, Podoltsev, Nikolai, Williams, Robert T., Rampal, Raajit K., Tallman, Martin S., Zeidan, Amer M., Stahl, Maximilian
Format: Artigo
Jezik:Inglês
Izdano: 2020
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7541411/
https://ncbi.nlm.nih.gov/pubmed/32669244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2020.05.018
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki